id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-330869-k5ro0edf	Kumar Singh, Awadhesh	Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A Narrative Review	2020-06-11		.txt	text/plain	5023	218	43	Not only 50% of population was found to have diabetes during the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) outbreak in 2012, but patients with diabetes had an odds ratio (OR) of 7.2 to 15.7 for severe or critical type of MERS-CoV infection with a relative high 35% rate of mortality, compared to the overall population [3] [4] [5] . In a large retrospective study (n=7337), Zhu et al reported a significant 49% relative increase in all-cause mortality (HR 1.49; 95% CI, 1.13-1.96; p=0.005) in patients with diabetes (n=810), compared to the groups without diabetes (n=6385) and COVID-19 even after the adjustment of multiple confounding factors [42] . However, available studies clearly suggest that the patients with diabetes had a significantly higher severe variety of COVID-19 as well as increased mortality, compared to the cohorts without diabetes.	./cache/cord-330869-k5ro0edf.txt	./txt/cord-330869-k5ro0edf.txt